Clinical trial
Effectiveness of BufferGel as a Vaginal Contraceptive
NCT00065858 · Premier Research, Other · Completed
Key facts
| NCT number | NCT00065858 |
|---|---|
| Title | Effectiveness of BufferGel as a Vaginal Contraceptive |
| Official title | A Randomized, Controlled Trial of the Efficacy, Safety, and Acceptability of BufferGel |
| Lead sponsor | Premier Research, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pregnancy |
| Intervention type | Drug |
| Interventions | BufferGel |
| Enrollment | 975 |
| Start date | Sep 1, 2001 |
| Completion | Apr 1, 2005 |
| First posted | Aug 5, 2003 |
| Last update posted | Aug 19, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: